OTC · Medical - Devices

Euroapi S.A. (EAPIF) Stock

$1.51 +0.00% OTC: EAPIF Healthcare

Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermediary compounds. These essential materials are then utilized in the formulation of a wide array of medicinal products for both human and veterinary applications.

Valuation

MetricValue
Price$1.51
Market Cap$144.31M
P/E Ratio-0.29
P/B Ratio0.14
P/S Ratio0.12
EPS (TTM)$-2.23
52-Week High$3.65
52-Week Low$1.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-44.53%
ROA-26.11%
ROCE-1.92%
Gross Margin15.40%
Operating Margin-2.13%
Net Margin-40.90%
Debt/Equity0.16
Current Ratio2.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$893.0M$981.0M$1.0B$919.0M$848.0M
Operating Profit$-13.0M$-1.0M$-234.0M$-120.0M$0
Net Profit$-8.0M$-15.0M$-190.0M$-131.0M$-211.0M
EPS$-0.09$-0.16$-2.01$-1.38$-2.23
Op Margin-1.4%-0.1%-23.0%-13.1%0.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.6B$1.7B$1.6B$1.5B$1.3B
Total Liabilities$607.0M$626.0M$685.0M$506.0M$517.0M
Cash$10.0M$75.0M$35.0M$73.0M$114.0M
Borrowings$24.0M$121.0M$226.0M$69.0M$65.0M

Latest News

EUROAPI_Availability of 2026 Half-year results financial report GlobeNewswire · Jul 31, 2026 First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site GlobeNewswire · Jul 29, 2026 Euroapi (ENXTPA:EAPI) Stock Fair Value Falls As Analysts Reset Growth And Margin Views Simply Wall St. · Jul 1, 2026 Combined General Meeting of May 27, 2026 GlobeNewswire · May 27, 2026 EUROAPI statement regarding the Brindisi site GlobeNewswire · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$72.0M$45.0M$5.0M$123.0M$125.0M
Investing Cash Flow$-176.0M$-335.0M$-270.0M$-216.0M$-155.0M
Financing Cash Flow$25.0M$1.0M$-13.0M$182.0M$-5.0M
Net Cash Flow$10.0M$64.0M$-40.0M$41.0M$49.0M
Free Cash Flow$-17.0M$-123.0M$-128.0M$15.0M$47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.81
FCF Yield-39.44%
Quick Ratio0.58
Interest Coverage-0.94
Return 1Y-58.63%
Return 3Y-87.69%
Return 5Y—

Ownership

Insiders Held34.84%
Institutions Held35.97%
Institutions Float Held55.19%
Institutional HolderSharesReport Date
Datum One Series Trust-BRANDES INTERNATIONAL SMALL CAP EQUITY FUND1,528,0182026-03-31
American Century ETF Trust-Avantis International Small Cap Value ETF637,0172026-06-30
DFA INVESTMENT TRUST CO-The Continental Small Company Series87,4842026-04-30
ADVISORS' INNER CIRCLE FUND II-KOPERNIK GLOBAL ALL-CAP FUND77,1022026-04-30
American Century ETF Trust-Avantis International Equity ETF70,4832026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLVLFClinuvel Pharmaceuticals Limited $6.37 +0.00% 13.94 $321.12M 0.47%
CMVLFCellectis S.A. $3.47 +12.66% -4.24 $251.93M 0.00%
CYDYCytoDyn Inc. $0.19 +0.00% -5.94 $260.25M 0.00%
DMTRF3-D Matrix, Ltd. $2.50 +0.00% 10.15 $319.95M 0.00%
IOBCFIon Beam Applications S.A. $17.93 +0.00% 36.50 $525.85M 1.62%

About Euroapi S.A.

Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermediary compounds. These essential materials are then utilized in the formulation of a wide array of medicinal products for both human and veterinary applications.

Euroapi S.A. is headquartered in FR.

Euroapi S.A. (EAPIF) stock trades at $1.51 with a market capitalization of $144.31M. The stock is valued at a price-to-earnings (P/E) ratio of -0.29, price-to-book of 0.14, price-to-sales of 0.12. Over the past 52 weeks the stock has ranged between $1.27 and $3.65, and currently trades 58.6% below its 52-week high.

On profitability, Euroapi S.A. generates a return on equity (ROE) of -44.53%, return on capital employed of -1.92%, an operating margin of -2.13%, a net profit margin of -40.90%.

Official website: www.euroapi.com/en

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides